Crossmark

Adverse events in single-arm clinical trials with non-fatal time-to-event efficacy endpoint: from clinical questions to methods for statistical analysis

Crossref DOI link: https://doi.org/10.1186/s12874-023-02123-z

Published Online: 2024-01-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tassistro, Elena

Bernasconi, Davide Paolo

Valsecchi, Maria Grazia

Antolini, Laura
Funding

Funding for this research was provided by:

Grant PRIN project (20178S4EK9, 20178S4EK9)
License Information

Text and Data Mining valid from 2024-01-03

Version of Record valid from 2024-01-03
More Information

Article History

Received: 19 May 2023

Accepted: 7 December 2023

First Online: 3 January 2024

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below